Monika D. Joshi

Oncology

500 University Dr
Hershey, PA 17033

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium.

COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium.

Journal: JCO oncology advances

Published: September 01, 2026

The sponsor-proxy model: Bridging basic science discovery and investigator-initiated clinical trials.

The sponsor-proxy model: Bridging basic science discovery and investigator-initiated clinical trials.

Journal: Journal of clinical and translational science

Published: April 06, 2026

Antibody-drug conjugates for bladder sparing: lessons from SURE-02 trial.

Antibody-drug conjugates for bladder sparing: lessons from SURE-02 trial.

Journal: The Lancet. Oncology

Published: February 08, 2026

Facilitating Advance Care Planning Conversations Among Patients With Cancer and Their Care Partners Utilizing a Conversation Game: A Pilot Study.

Facilitating Advance Care Planning Conversations Among Patients With Cancer and Their Care Partners Utilizing a Conversation Game: A Pilot Study.

Journal: Cancer reports (Hoboken, N.J.)

Published: December 20, 2024

Perioperative immunotherapy in urothelial carcinoma: AMBASSADOR charts the path forward.

Perioperative immunotherapy in urothelial carcinoma: AMBASSADOR charts the path forward.

Journal: Med (New York, N.Y.)

Published: October 21, 2024

Management options for node-positive muscle-invasive bladder cancer.

Management options for node-positive muscle-invasive bladder cancer.

Journal: Clinical advances in hematology & oncology : H&O

Published: October 02, 2024

Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets.

Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets.

Journal: Pharmaceutical research

Published: September 20, 2024

Interferon-γ/Janus Kinase 1/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer.

Interferon-γ/Janus Kinase 1/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer.

Journal: The American journal of pathology

Published: August 27, 2024

Editorial: Innovative molecular therapeutic approaches in urothelial carcinoma.

Editorial: Innovative molecular therapeutic approaches in urothelial carcinoma.

Journal: Frontiers in oncology

Published: May 09, 2024

Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer.

Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer.

Journal: Urology practice

Published: February 02, 2024

FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new treatment landscape.

FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new treatment landscape.

Journal: Med (New York, N.Y.)

Published: November 29, 2023

Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.

Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.

Journal: JAMA oncology

Published: August 17, 2023

Showing 1-12 of 82

Last Updated: 09/26/2026